Related Experiment Video
Updated: Feb 8, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy
Payal Malhotra1, Gauri Kapoor2, Sandeep Jain1
1Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Insights
Pediatric acute lymphoblastic leukemia (ALL) therapy is linked to a high incidence of hypertension in children. Younger age and constipation were identified as key risk factors for developing high blood pressure during ALL treatment.
Area of Science:
- Pediatric Oncology
- Pediatric Cardiology
- Hematology
Background:
- Hypertension is a potential complication in pediatric cancer treatment.
- Understanding risk factors for hypertension during acute lymphoblastic leukemia (ALL) therapy is crucial for patient management.
Purpose of the Study:
- To determine the incidence of hypertension in pediatric patients during induction and re-induction phases of ALL therapy.
- To identify potential risk factors associated with the development of hypertension in this population.
Main Methods:
- Retrospective analysis of 208 pediatric patients (<18 years) with ALL treated per the BFM-95 protocol.
- Data collected between January 2009 and December 2013.
- Statistical analysis to determine hypertension incidence and associated risk factors.
Main Results:
- The incidence of hypertension requiring medication was 29% during induction and 17% during re-induction.
- The median age of affected patients was 4 years.
- Multivariate analysis identified age under 10 years and constipation as independent predictors of hypertension.
Conclusions:
- A significant incidence of hypertension occurs in children undergoing ALL induction therapy.
- Early identification of risk factors like young age and constipation can aid in managing hypertension during ALL treatment.
Objective:
To determine the incidence of hypertension among children during the induction and re-induction phases of acute lymphoblastic leukemia (ALL) therapy and association with possible risk factors.
Methods:
A retrospective analysis of 208 consecutive pediatric (age <18 y) ALL patients, treated per BFM-95 protocol between January 2009 and December 2013. Data were analyzed to determine the incidence of hypertension and risk factors for its development.
Results:
Incidence of hypertension requiring antihypertensive medication, was 29% (61/208) during induction and 17% (33/198) during re-induction (P=0.003). Median (range) age of patients developing hypertension was 4 y (4 mo to 8 y). Age <10 y and presence of constipation were independently predictive of hypertension by multivariate analysis.
Conclusions:
The present study reports a high incidence of hypertension among children undergoing ALL induction therapy.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Relative Risk
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...

